老虎证券

BUZZ-Marker Therapeutics jumps after blood cancer trial data

Reuters
2025/08/26
BUZZ-Marker <a href="https://laohu8.com/S/LENZ">Therapeutics</a> jumps after blood cancer trial data

** Shares of drug developer Marker Therapeutics MRKR.O up 29% at $1.63 premarket

** Co reports data from its ongoing early-stage trial testing its experimental therapy, MT-601, in patients with relapsed B-cell lymphoma, a type of blood cancer that has returned after previous treatment

** Co says 66% of patients saw their cancer shrink or disappear, with 50% showing no detectable cancer after treatment

** The therapy had no severe side effects, co says

** As of last close, stock down 60% YTD

(Reporting by Kamal Choudhury in Bengaluru)

((Kamal.Choudhury@thomsonreuters.com;))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10